Ferritin Quantitative Test

HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)

HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.

Product Detail

Application

HbA1c is a product of the non-enzymatic chemical reaction between glucose and the N-terminus of the hemoglobin protein's β-chain (valine) amino groups. From a molecular biology perspective, HbA1c belongs to a diverse group of molecules termed advanced glycation end-products (AGEs).

 

In both diabetic and non-diabetic individuals, the relative levels of HbA1c reflect the duration and severity of hyperglycemic episodes, as well as the overall exposure to extracellular glucose present in the circulation. HbA1c levels, at varying cut-offs, have been developed as biomarkers for both the diagnosis of diabetes and the assessment of chronic glycemic control.

 

HbA1c reflects the average plasma glucose concentration over the previous 8 to 12 weeks. It can be measured at any time of the day and does not require special preparation, such as fasting. These properties have made HbA1c the preferred test for assessing glycemic control in people with diabetes.

 

More recently, there has been substantial interest in using HbA1c as a diagnostic test for diabetes and as a screening test for individuals at high risk of developing the condition. The use of HbA1c can avoid the problem of day-to-day variability in glucose values and eliminates the need for fasting and preceding dietary preparations. These advantages have important implications for the early identification and treatment of diabetes, which have been strongly advocated in recent years.

 

A persistently elevated level of HbA1c increases the risk of various vascular complications, such as coronary disease, heart attack, stroke, heart failure, kidney failure, blindness, erectile dysfunction, neuropathy, gangrene, gastroparesis, and short-term complications of surgery, including poor wound healing.

 

Product Specification

Sample Volume

WB: 10μL

Test Time

15 mins

Measuring Range

4.2-20%

Pack

20T40T100T

Storage

2~30

 

Features

Smart - Photosensitive and Luminescent Microspheres

Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed

Convenient - Room Temperature Storage & Minimal sample consumption

 

Clinical significance

Diagnosis and Monitoring of Diabetes

Assessment of Long-Term Blood Glucose Control

Cardiovascular Risk Assessment

Medication Adjustment and Treatment Planning

Screening for Prediabetes

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)
C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)
C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-peptide concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Insulin (INS) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.
FIA Analyzer
FLI-100 FIA Analyzer
The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.
hs cTnI Rapid Quantitative Test
hs cTnI Rapid Quantitative Test
cTnI, a crucial cardiac biomarker, assists in detecting and managing acute myocardial infarction and assessing patient risk in cardiovascular events. Biotime's hs-cTnI offers high sensitivity, compatibility with versatile samples, and stable performance. Trust our ideal biomarker for comprehensive acute coronary syndrome evaluation.
SAA Rapid Quantitative Test (Chemiluminescence Immunoassay)
SAA Rapid Quantitative Test (Chemiluminescence Immunoassay)
SAA Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Serum amyloid A (SAA) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.
h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay)
h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay)
h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the heart-type fatty acid binding protein (h-FABP) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
bioitime TT4 Rapid Quantitative Test
TT4 Rapid Quantitative Test
TT4 is the main product of thyroid secretion and is an essential ingredient in the integrity of the hypothalamic-pituitary gland. The TT4 measures can be used for the diagnosis of hyperthyroidism, primary and secondary, and TT4 inhibition of treatment.
β-HCG Rapid Quantitative Test (Chemiluminescence Immunoassay
β-HCG Rapid Quantitative Test (Chemiluminescence Immunoassay
β-HCG Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the β-human chorionic gonadotropin (β-HCG) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact